Davison Sara N, Jhangri Gian S, Feeny David H
Division of Nephrology & Immunology, University of Alberta, Edmonton, AB, Canada.
Qual Life Res. 2008 Aug;17(6):933-42. doi: 10.1007/s11136-008-9354-1. Epub 2008 Jun 10.
This study assessed the construct validity of the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3) in the context of chronic kidney disease (CKD) and compared their ability to discriminate between groups of patients with varying disease severity.
The HUI2 and HUI3 were correlated with the Medical Outcomes 36-Item Short-Form, Kidney Disease Quality of Life Questionnaire, and the Beck Depression Inventory II in 185 patients with stage 4 and 5 CKD.
About 86% of a priori hypotheses were confirmed for HUI2 and 95% for HUI3, providing support for the construct validity of both measures. Mean (SD) overall utility score for the HUI2 was 0.74 (0.20), significantly higher than that for the HUI3, 0.58 (0.26) (P<0.001). The cognitive, emotion, and pain attributes of the HUI3 were able to identify a significantly greater proportion of patients with impairment compared to the HUI2.
The results are consistent with construct validity for the HUI2 and HUI3 in patients with stage 4 and 5 CKD. However, the HUI3 appears to have superior psychometric properties compared with the HUI2 in this patient population.
本研究评估了健康效用指数Mark 2(HUI2)和Mark 3(HUI3)在慢性肾脏病(CKD)背景下的结构效度,并比较了它们区分不同疾病严重程度患者组的能力。
在185例4期和5期CKD患者中,将HUI2和HUI3与医学结局简明36项量表、肾脏疾病生活质量问卷以及贝克抑郁量表第二版进行相关性分析。
HUI2约86%的先验假设得到证实,HUI3为95%,这为两种测量方法的结构效度提供了支持。HUI2的平均(标准差)总体效用评分为0.74(0.20),显著高于HUI3的0.58(0.26)(P<0.001)。与HUI2相比,HUI3的认知、情感和疼痛属性能够识别出比例显著更高的受损患者。
结果与HUI2和HUI3在4期和5期CKD患者中的结构效度一致。然而,在该患者群体中,HUI3似乎比HUI2具有更好的心测量学特性。